Prescription drug · NDA
Qutenza (Capsaicin) NDC 72512-930
Kit · Averitas Pharma Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72512-930-01 | 72512093001 | 1 KIT in 1 CARTON (72512-930-01) * 4 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 179 mg in 1 PATCH * 3 TUBE in 1 CARTON / 50 g in 1 TUBEMarketed from Mar 25, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Qutenza
- Generic name (nonproprietary)
- capsaicin
- Dosage form
- Kit
- Labeler
- Averitas Pharma IncNDC labeler code 72512
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022395
- Marketing start
- Listing expires
- Identifiers
- Product ID 72512-930_fca75aa2-8651-42c5-9a72-74054a10452bSPL ID fca75aa2-8651-42c5-9a72-74054a10452bSPL set ID 3ffbbcb0-ad93-4f15-bb38-5da76a71c735RxCUI 1039679, 1039681
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N472512093001followed by a unit qualifier and the quantityPackage 72512-0930-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
QUTENZA is indicated in adults for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and for neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet. QUTENZA is a TRPV1 channel agonist indicated for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 72512-930
- What is NDC 72512-930?
- 72512-930 is the product NDC for Qutenza (capsaicin) kit, listed with the FDA by Averitas Pharma Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Qutenza (Capsaicin).
- Who is the labeler?
- Averitas Pharma Inc, NDC labeler code 72512. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Qutenza?
- 2 other product NDCs are listed under this name. See all Qutenza NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Qutenza products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Qutenzacapsaicin | — | Kit | Averitas Pharma Inc | 72512-928 | 72512-0928-01 |
| Qutenzacapsaicin | — | Kit | Averitas Pharma Inc | 72512-929 | 72512-0929-01 |
Other NDCs under NDA 022395
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Qutenzacapsaicin | — | Kit | Averitas Pharma Inc | 72512-928 |
| Qutenzacapsaicin | — | Kit | Averitas Pharma Inc | 72512-929 |